The American Hospital Association urges Congress to use oversight authority as Eli Lilly informs HRSA of its 340B program changes.
7 reports, 3 independent
Updated Aug 1
Gone quiet
- Reports
- 7
- Developments
- 2
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The American Hospital Association urges Congress to use oversight authority as Eli Lilly informs HRSA of its 340B program changes.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.AHA objects to HRSA's revised 340B Rebate Model Pilot Program.1 source
Healthcare policy debate: AHA urges Congress to oversee Eli Lilly's 340B program changes with HRSA.1 source
Keep exploring
The entities involved
-
Congress
US record label; imprint of Congress Record Corp.
-
American Hospital Association
health care industry trade group
-
Health Resources and Services Administration
United States government agency
-
Eli Lilly and Company
American pharmaceutical company